DL-Penicillamine

CAS No. 52-66-4

DL-Penicillamine ( —— )

Catalog No. M14864 CAS No. 52-66-4

The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 61 In Stock
50MG 98 In Stock
100MG 129 In Stock
200MG 181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DL-Penicillamine
  • Note
    Research use only, not for human use.
  • Brief Description
    The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
  • Description
    The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    52-66-4
  • Formula Weight
    149.21
  • Molecular Formula
    C5H11NO2S
  • Purity
    >98%(HPLC)
  • Solubility
    Free soluble in Water
  • SMILES
    CC(C)(S)C(N)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Brewer GJ. Expert Opin PharmacOthers. 2006, 7(3):317-24
molnova catalog
related products
  • 1-Acetyl-beta-carbol...

    Combination of 1-acetyl-beta-carboline with ampicillin exhibits synergistic antibacterial activity against MRSA.

  • 12-Dipalmitoyl-sn-gl...

    12-Dipalmitoyl-sn-glycerol is an analog of the PKC-activating second messenger diacylglycerol (DAG). It weakly activates PKC.

  • GSK-626616

    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.